H. Kjellman

582 total citations
20 papers, 462 citations indexed

About

H. Kjellman is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, H. Kjellman has authored 20 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 4 papers in Genetics and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in H. Kjellman's work include Hemophilia Treatment and Research (10 papers), Blood groups and transfusion (9 papers) and Platelet Disorders and Treatments (6 papers). H. Kjellman is often cited by papers focused on Hemophilia Treatment and Research (10 papers), Blood groups and transfusion (9 papers) and Platelet Disorders and Treatments (6 papers). H. Kjellman collaborates with scholars based in Sweden, Finland and United States. H. Kjellman's co-authors include Olle Eriksson, M Schannong, A Ahlberg, Sten Iwarson, Per Olov Hedlund, L. Andersson, Britta Lindqvist, Svante Hermodsson, D. Selander and E Eriksson and has published in prestigious journals such as The Journal of Infectious Diseases, Acta Paediatrica and The American Journal of the Medical Sciences.

In The Last Decade

H. Kjellman

20 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Kjellman Sweden	13	213	174	105	64	49	20	462
J. McCullough Netherlands	4	265 1.2×	200 1.1×	35 0.3×	45 0.7×	49 1.0×	5	450
Shan Yuan United States	10	117 0.5×	82 0.5×	58 0.6×	89 1.4×	73 1.5×	16	418
Laurent Bardiaux France	11	277 1.3×	444 2.6×	58 0.6×	66 1.0×	146 3.0×	26	725
C. Elliott United Kingdom	5	232 1.1×	145 0.8×	51 0.5×	40 0.6×	95 1.9×	6	455
Barbro Wiechel Sweden	9	186 0.9×	62 0.4×	22 0.2×	32 0.5×	14 0.3×	15	329
Debra Masel United States	14	512 2.4×	494 2.8×	81 0.8×	38 0.6×	132 2.7×	25	816
Leigh C. Jefferies United States	11	136 0.6×	64 0.4×	33 0.3×	24 0.4×	41 0.8×	20	310
Mary Jo Drew United States	5	131 0.6×	152 0.9×	31 0.3×	20 0.3×	134 2.7×	8	348
Meenu Bajpai India	15	127 0.6×	83 0.5×	111 1.1×	318 5.0×	98 2.0×	52	721
Manuel Jesús Romero-Jiménez Spain	11	40 0.2×	40 0.2×	105 1.0×	51 0.8×	11 0.2×	24	508

Countries citing papers authored by H. Kjellman

Since Specialization

Citations

This map shows the geographic impact of H. Kjellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kjellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kjellman more than expected).

Fields of papers citing papers by H. Kjellman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kjellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kjellman. The network helps show where H. Kjellman may publish in the future.

Co-authorship network of co-authors of H. Kjellman

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kjellman. A scholar is included among the top collaborators of H. Kjellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kjellman. H. Kjellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Messori, Andrea, Massimo Morfini, Margareta Blombäck, et al.. (1992). Pharmacokinetics of two pasteurized Factor VIII concentrates by different and multicenter assays of Factor VIII activity. Thrombosis Research. 65(6). 699–708. 12 indexed citations

Cinotti, S., Giovanni Longo, Andrea Messori, et al.. (1991). Reproducibility of one-stage, two-stage and chromogenic assays of factor VIII activity: A multi-center study. Thrombosis Research. 61(4). 385–393. 12 indexed citations

WADSWORTH, C., et al.. (1989). Some characteristics of aggregates of IgG and plasma proteins in heat-treated factor VIII concentrates. Annals of Hematology. 58(3). 133–141. 5 indexed citations

Blombäck, Margareta, H. Kjellman, Jean‐Pierre Allain, et al.. (1987). On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentrates. Scandinavian Journal of Clinical and Laboratory Investigation. 47(6). 561–566. 8 indexed citations

Blombäck, Margareta, H. Kjellman, Nils Egberg, et al.. (1987). Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up. Infection. 15(4). 248–252. 5 indexed citations

WADSWORTH, C., et al.. (1985). Complexes of IgG and Plasma Proteins in Factor VIII Preparations — a Possible Cause of Adverse Reactions. Vox Sanguinis. 49(5). 319–322. 13 indexed citations

Kjellman, H., et al.. (1984). Antenatal prophylaxis of Rh immunization with 250 μg anti‐D immunoglobulin. Acta Obstetricia Et Gynecologica Scandinavica. 63(S124). 1–15. 13 indexed citations

Kjellman, H.. (1984). Calculations of Factor VIII in vivo Recovery and Half‐life. Scandinavian Journal of Haematology. 33(S40). 165–174. 24 indexed citations

Wahl, Martin, Svante Hermodsson, H. Kjellman, & Sten Iwarson. (1983). Recovery and turnover rate of hepatitis B immunoglobulin in volunteers.. PubMed. 54. 341–5. 8 indexed citations

10.

Kjellman, H., et al.. (1982). Turnover rate of anti-D IgG injected during pregnancy.. BMJ. 284(6319). 854–855. 22 indexed citations

11.

Norkrans, Gunnar, et al.. (1981). Acute Hepatitis Non‐A, Non‐B following Administration of Factor VIII Concentrates. Vox Sanguinis. 41(3). 129–133. 24 indexed citations

12.

Hattevig, Gunnar, Maria Jonsson, Bengt Kjellman, et al.. (1981). SCREENING OF RH-ANTIBODIES IN RH-NEGATIVE FEMALE INFANTS WITH RH-POSITIVE MOTHERS. Acta Paediatrica. 70(4). 541–545. 9 indexed citations

13.

Andersson, L., Olle Eriksson, Per Olov Hedlund, H. Kjellman, & Britta Lindqvist. (1978). Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Urological Research. 6(2). 83–8. 53 indexed citations

14.

Gíslason, Davíð, et al.. (1978). Intravenous γ‐Globulin Infusions in Patients with Hypo‐γ‐Globulinemia¹. Vox Sanguinis. 34(3). 143–148. 14 indexed citations

15.

Iwarson, Sten, J Ahlmén, E Eriksson, et al.. (1977). Hepatitis B Immune Globulin in Prevention of Hepatitis B among Hospital Staff Members. The Journal of Infectious Diseases. 135(3). 473–477. 24 indexed citations

16.

Iwarson, Sten, H. Kjellman, & Ann‐Catrine Teger‐Nilsson. (1976). Incidence of Viral Hepatitis after Administration of Factor IX Concentrates. Vox Sanguinis. 31(2). 136–140. 15 indexed citations

17.

Kjellman, H., et al.. (1976). Rh‐Prophylaxis with Immunoglobulin Anti‐D Administered during Pregnancy and after Delivery. Acta Obstetricia Et Gynecologica Scandinavica. 55(S49). 1–11. 10 indexed citations

18.

Ahlberg, A, Olle Eriksson, & H. Kjellman. (1976). Diffusion of Tranexamic Acid to the Joint. Acta Orthopaedica Scandinavica. 47(5). 486–488. 56 indexed citations

19.

Iwarson, Sten, H. Kjellman, J Ahlmén, et al.. (1975). Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff. The American Journal of the Medical Sciences. 270(2). 385–390. 16 indexed citations

20.

Eriksson, Olle, et al.. (1974). Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. European Journal of Clinical Pharmacology. 7(5). 375–380. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact